These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
269 related articles for article (PubMed ID: 29624704)
1. Implementation Science to Advance Care Delivery: A Primer for Pharmacists and Other Health Professionals. Livet M; Haines ST; Curran GM; Seaton TL; Ward CS; Sorensen TD; Roth McClurg M Pharmacotherapy; 2018 May; 38(5):490-502. PubMed ID: 29624704 [TBL] [Abstract][Full Text] [Related]
2. Pharmacists as mid-level practitioners/providers. Ross LA Ann Pharmacother; 2011 Jun; 45(6):810-2. PubMed ID: 21666080 [TBL] [Abstract][Full Text] [Related]
3. CPD and revalidation: our future is happening now. Austin Z Res Social Adm Pharm; 2013; 9(2):138-41. PubMed ID: 23062784 [TBL] [Abstract][Full Text] [Related]
4. Integrating pharmacists into diverse diabetes care teams: implementation tactics from Project IMPACT: Diabetes. Watson LL; Bluml BM J Am Pharm Assoc (2003); 2014; 54(5):538-41. PubMed ID: 25216884 [TBL] [Abstract][Full Text] [Related]
5. Involving systems thinking and implementation science in pharmacists' emerging role to facilitate the safe and appropriate use of traditional and complementary medicines. Harnett JE; Desselle SP; Hu H; Ung COL Hum Resour Health; 2020 Aug; 18(1):55. PubMed ID: 32746844 [TBL] [Abstract][Full Text] [Related]
6. Strategies to facilitate the implementation of collaborative practice agreements in chain community pharmacies. Bacci JL; Coley KC; McGrath K; Abraham O; Adams AJ; McGivney MS J Am Pharm Assoc (2003); 2016; 56(3):257-265.e2. PubMed ID: 27053276 [TBL] [Abstract][Full Text] [Related]
7. Implementation science as a leadership capability to improve patient outcomes and value in healthcare. Votova K; Laberge AM; Grimshaw JM; Wilson B Healthc Manage Forum; 2019 Nov; 32(6):307-312. PubMed ID: 31446791 [TBL] [Abstract][Full Text] [Related]
8. Recognition of community-based pharmacist practitioners: Essential health care providers. Bennett M; Goode JV J Am Pharm Assoc (2003); 2016; 56(5):580-3. PubMed ID: 27594108 [TBL] [Abstract][Full Text] [Related]
9. Integrating pharmacogenomics into pharmacy practice via medication therapy management. Reiss SM; J Am Pharm Assoc (2003); 2011; 51(6):e64-74. PubMed ID: 22001957 [TBL] [Abstract][Full Text] [Related]
10. Consortium recommendations for advancing pharmacists' patient care services and collaborative practice agreements. American Pharmacists Association Foundation and American Pharmacists Association J Am Pharm Assoc (2003); 2013; 53(2):e132-41. PubMed ID: 23571636 [TBL] [Abstract][Full Text] [Related]
11. Design of the POINT study: Pharmacotherapy Optimisation through Integration of a Non-dispensing pharmacist in a primary care Team (POINT). Hazen AC; Sloeserwij VM; Zwart DL; de Bont AA; Bouvy ML; de Gier JJ; de Wit NJ; Leendertse AJ BMC Fam Pract; 2015 Jul; 16():76. PubMed ID: 26135582 [TBL] [Abstract][Full Text] [Related]
12. Integration of pharmacists into a patient-centered medical home. Scott MA; Hitch B; Ray L; Colvin G J Am Pharm Assoc (2003); 2011; 51(2):161-6. PubMed ID: 21382805 [TBL] [Abstract][Full Text] [Related]
13. DOTx. MED: Pharmacist-delivered interventions to improve care for patients with diabetes. American Pharmacists Association J Am Pharm Assoc (2003); 2012; 52(1):25-33. PubMed ID: 22173068 [TBL] [Abstract][Full Text] [Related]
14. Medication therapy management in pharmacy practice: core elements of an MTM service model (version 2.0). ; J Am Pharm Assoc (2003); 2008; 48(3):341-53. PubMed ID: 18595820 [TBL] [Abstract][Full Text] [Related]
15. Clinical Pharmacists in Correctional Facilities: A Literature Review and Future Directions. Thomson C; Gunther M; Macek P J Correct Health Care; 2019 Jul; 25(3):201-213. PubMed ID: 31122114 [TBL] [Abstract][Full Text] [Related]
16. Implementation of targeted medication adherence interventions within a community chain pharmacy practice: The Pennsylvania Project. Bacci JL; McGrath SH; Pringle JL; Maguire MA; McGivney MS J Am Pharm Assoc (2003); 2014; 54(6):584-93. PubMed ID: 25379980 [TBL] [Abstract][Full Text] [Related]
17. 2017 Prescott Lecture: Bridging the intersection between pharmacy, advocacy, and value-based care. Wagner A J Am Pharm Assoc (2003); 2017; 57(4):439-441. PubMed ID: 28712462 [No Abstract] [Full Text] [Related]
18. Stakeholder analysis for the development of a community pharmacy service aimed at preventing cardiovascular disease. Franco-Trigo L; Hossain LN; Durks D; Fam D; Inglis SC; Benrimoj SI; Sabater-Hernández D Res Social Adm Pharm; 2017; 13(3):539-552. PubMed ID: 27485770 [TBL] [Abstract][Full Text] [Related]
19. APhA 2011 REMS white paper: Summary of the REMS stakeholder meeting on improving program design and implementation. American Pharmacists Association ; Bough M J Am Pharm Assoc (2003); 2011; 51(3):340-58. PubMed ID: 21555285 [TBL] [Abstract][Full Text] [Related]
20. Best practices: improving patient outcomes and costs in an ACO through comprehensive medication therapy management. Brummel A; Lustig A; Westrich K; Evans MA; Plank GS; Penso J; Dubois RW J Manag Care Spec Pharm; 2014 Dec; 20(12):1152-8. PubMed ID: 25597053 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]